[Federal Register Volume 87, Number 204 (Monday, October 24, 2022)]
[Notices]
[Pages 64242-64243]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-23054]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Agency Information Collection Activities: Submission for OMB 
Review; Comment Request

    Periodically, the Substance Abuse and Mental Health Services 
Administration (SAMHSA) will publish a summary of information 
collection requests under Office of Management and Budget (OMB) review, 
in compliance with the Paperwork Reduction Act (44 U.S.C. chapter 35). 
To request a copy of these documents, email or call the SAMHSA Reports 
Clearance Officer at [email protected] or (240) 276-0361.

Proposed Project: Program Evaluation for Prevention Contract (PEPC)--
Strategic Prevention Framework for Prescription Drugs (SPF-Rx) 
Evaluation (OMB No. 0930-0377)--Revision

    The Substance Abuse and Mental Health Services Administration's 
(SAMHSA) Center for Behavioral Health Statistics and Quality (CBHSQ) 
aims to complete a cross-site evaluation of SAMHSA's Strategic 
Prevention Framework for Prescription Drugs (SPF-Rx). SPF-Rx is 
designed to address nonmedical use of prescription drugs as well as 
opioid overdoses by raising awareness about the dangers of sharing 
medications and by working with pharmaceutical and medical communities 
on the risks of overprescribing. The SPF-Rx program aims to promote 
collaboration between

[[Page 64243]]

states/tribes and pharmaceutical and medical communities to understand 
the risks of overprescribing to youth ages 12-17 and adults 18 years of 
age and older. The program also aims to enhance capacity for, and 
access to, Prescription Drug Monitoring Program (PDMP) data for 
prevention purposes. This request for data collection includes a 
revision from previously approved OMB instruments.
    The SPF-Rx program's indicators of success are reductions in opioid 
overdoses, reductions in prescription drug misuse, and improved use of 
PDMP data. Data collected through the tools described in this statement 
will be used for the national cross-site evaluation of SAMHSA's SPF-Rx 
program. This package covers continued data collection through 2025. 
The Program Evaluation for Prevention Control (PEPC) team will 
systematically collect and maintain an Annual Reporting Tool (ART) and 
Grantee and Community Level Outcomes data modules submitted by SPF-Rx 
grantees through the online Data Management System (DMS).
    SAMHSA is requesting approval for data collection for the SPF-Rx 
cross-site evaluation with the following instruments:
     Annual Reporting Tool (ART)--The ART is a survey 
instrument collected yearly to monitor state, tribal entity, and 
community-level performance, and to evaluate the effectiveness of the 
SPF-Rx program. This tool is completed by grantees and subrecipient 
community project directors and provides process data related to 
funding use and effectiveness, organizational capacity, collaboration 
with community partners, data infrastructure, planned intervention 
targets, intervention implementation, evaluation, contextual factors, 
training and technical assistance (T/TA) needs, and sustainability.
     Grantee-and Community-Level Outcomes Modules--These 
modules collect data on key SPF-Rx program outcomes, including opioid 
prescribing patterns and provider use of PDMP. Grantees will provide 
outcomes data at the grantee level for their state, tribal area, or 
jurisdiction, as well as at the community level for each of their 
subrecipient communities.
     Grantee-Level Interview--This qualitative interview will 
be administered at the end of the evaluation to obtain information from 
the grantee project directors on their programs, staffing, populations 
of focus, infrastructure, capacity, lessons learned, and collaboration.

                                    Annualized Data Collection Burden by Year
----------------------------------------------------------------------------------------------------------------
                                     Number of     Responses per   Total number      Hours per     Total burden
           Instrument               respondents     respondent     of responses      response          hours
----------------------------------------------------------------------------------------------------------------
Annual Reporting Tool...........         \a\ 110               1             110               4             440
                                          \b\ 21               1              21               3              63
Grantee-Level PDMP Outcomes               \b\ 21               1              21             2.5            52.5
 Module.........................
Community-Level PDMP Outcomes             \b\ 21             5.2             110            1.25           137.5
 Module.........................
Grantee-Level Interview.........          \b\ 21               1              21             1.5            31.5
                                 -------------------------------------------------------------------------------
    FY2023......................             131  ..............             283  ..............           724.5
----------------------------------------------------------------------------------------------------------------
Annual Reporting Tool...........         \a\ 110               1             110               4             440
                                          \b\ 21               1              21               3              63
Grantee-Level PDMP Outcomes               \b\ 21               1              21             2.5            52.5
 Module.........................
Community-Level PDMP Outcomes             \b\ 21             5.2             110            1.25           137.5
 Module.........................
Grantee-Level Interview.........           \b\ 0             N/A             N/A             1.5             N/A
                                 -------------------------------------------------------------------------------
    FY2024......................             131  ..............             283  ..............             693
----------------------------------------------------------------------------------------------------------------
Annual Reporting Tool...........         \a\ 110               1             110               4             440
                                          \b\ 21               1              21               3              63
Grantee-Level PDMP Outcomes               \b\ 21               1              21             2.5            52.5
 Module.........................
Community-Level PDMP Outcomes             \b\ 21             5.2             110            1.25           137.5
 Module.........................
Grantee-Level Interview.........          \b\ 21               1              21             1.5            31.5
                                 -------------------------------------------------------------------------------
    FY2025......................             131  ..............             283  ..............           724.5
----------------------------------------------------------------------------------------------------------------
\a\ Community subrecipient respondent.
\b\ Grantee respondent.

    Written comments and recommendations for the proposed information 
collection should be sent within 30 days of publication of this notice 
to www.reginfo.gov/public/do/PRAMain. Find this particular information 
collection by selecting ``Currently under 30-day Review--Open for 
Public Comments'' or by using the search function.

Carlos Graham,
Reports Clearance Officer.
[FR Doc. 2022-23054 Filed 10-21-22; 8:45 am]
BILLING CODE 4162-20-P